Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 1 (2004), Issue 4 (December)

1. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects.
   Eur Heart J, 25(23): 2143-8. [Abstract] [Full-text]
2. Changes of cerebral hemodynamics in hypertensives during physical exercise.
   J Neuroimaging, 15(1): 64-9. [Abstract] [Full-text]
3. Race, rural residence, and control of diabetes and hypertension.
   Ann Fam Med, 2(6): 563-8. [Abstract] [Full-text]
4. Low-grade inflammation and microalbuminuria in hypertension.
   Arterioscler Thromb Vasc Biol, 24(12): 2414-9. [Abstract] [Full-text]
5. A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.
   J Am Soc Nephrol, 15(12): 3175-83. [Abstract] [Full-text]
6. Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle.
   Am J Physiol Renal Physiol, 288(1): F236-42. [Abstract] [Full-text]
7. Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats.
   Am J Nephrol, 24(5): 549-56. [Abstract] [Full-text]
8. The conduction of dilation along an arteriole is diminished in the cremaster muscle of hypertensive hamsters.
   J Vasc Res, 41(6): 517-24. [Abstract] [Full-text]
9. Rational pharmacotherapy in the diabetic hypertension: analysis-prescribing patterns in a general hospital in Taiwan.
   J Clin Pharm Ther, 29(6): 547-58. [Abstract] [Full-text]
10. Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure.
    J Hum Hypertens, 18: S9-S14. [Abstract] [Full-text]
11. The paradigm has shifted to systolic blood pressure.
    J Hum Hypertens, 18: S3-7. [Abstract] [Full-text]
12. The place of diuretics in preventing cardiovascular events.
    J Hum Hypertens, 18: S29-32. [Abstract] [Full-text]
13. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    J Hum Hypertens, 18: S23-8. [Abstract] [Full-text]
14. Diuretics for cardiovascular prevention in the elderly.
    J Hum Hypertens, 18: S15-22. [Abstract] [Full-text]
15. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Clin Pharmacol Ther, 76(6): 536-44. [Abstract] [Full-text]
16. Mortality and blood pressure in elderly people with and without cognitive impairment.
    Gerontology, 51(1): 53-61. [Abstract] [Full-text]
17. Effects of exercise and diet on chronic disease.
    J Appl Physiol, 98(1): 3-30. [Abstract] [Full-text]
18. The change of beta-adrenergic system after cessation of lead exposure.
    Toxicology, 207(1): 73-80. [Abstract] [Full-text]
19. Longitudinal studies on the effect of hypertension on circadian hemodynamic and autonomic rhythms in telemetered rats.
    Life Sci, 76(8): 901-15. [Abstract] [Full-text]
20. Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver.
    Biochimie, 86(11): 799-806. [Abstract] [Full-text]
21. Analysis of late risk of systemic blood pressures <120/80 mm Hg.
    Am J Cardiol, 94(12): 1575-6. [Abstract] [Full-text]
22. Prognostic value of 24-hour ambulatory blood pressure measurement for the onset of atrial fibrillation in treated patients with essential hypertension.
    Am J Cardiol, 94(12): 1566-9. [Abstract] [Full-text]
23. Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia.
    Am J Cardiol, 94(12): 1558-61. [Abstract] [Full-text]
24. Prehypertension and mortality in a nationally representative cohort.
    Am J Cardiol, 94(12): 1496-500. [Abstract] [Full-text]
25. Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition.
    Am J Physiol Regul Integr Comp Physiol, 288(1): R80-4. [Abstract] [Full-text]
26. Angiotensin-converting enzyme, sleep-disordered breathing, and hypertension.
    Am J Respir Crit Care Med, 170(12): 1349-53. [Abstract] [Full-text]
27. Prenatal programming of hypernatremia and hypertension in neonatal lambs.
    Am J Physiol Regul Integr Comp Physiol, 288(1): R97-103. [Abstract] [Full-text]
28. Cerebral pressure-flow relations in hypertensive elderly humans: transfer gain in different frequency domains.
    J Appl Physiol, 98(1): 151-9. [Abstract] [Full-text]
29. A high-fat, refined-carbohydrate diet induces endothelial dysfunction and oxidant/antioxidant imbalance and depresses NOS protein expression.
    J Appl Physiol, 98(1): 203-10. [Abstract] [Full-text]
30. Role of endothelin in mediating postmenopausal hypertension in a rat model.
    Am J Physiol Regul Integr Comp Physiol, 288(1): R229-33. [Abstract] [Full-text]
31. Erectile dysfunction: an early marker for hypertension? A longitudinal study in spontaneously hypertensive rats.
    Am J Physiol Regul Integr Comp Physiol, 288(1): R276-83. [Abstract] [Full-text]
32. Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial.
    Arch Intern Med, 164(22): 2459-64. [Abstract] [Full-text]
33. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.
    Circulation, 110(24): 3687-92. [Abstract] [Full-text]
34. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects.
    Circulation, 110(24): 3680-6. [Abstract] [Full-text]
35. The Gly482Ser polymorphism in the peroxisome proliferator-activated receptor-gamma coactivator-1 gene is associated with hypertension in type 2 diabetic men.
    Diabetologia, 47(11): 1980-3. [Abstract] [Full-text]
36. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    JAMA, 292(23): 2849-59. [Abstract] [Full-text]
37. Association between childhood and adulthood socioeconomic position and pregnancy induced hypertension: results from the Aberdeen children of the 1950s cohort study.
    J Epidemiol Community Health, 59(1): 49-55. [Abstract] [Full-text]
38. Generic obstetric database systems are unreliable for reporting the hypertensive disorders of pregnancy.
    Aust N Z J Obstet Gynaecol, 44(6): 505-9. [Abstract] [Full-text]
39. Quinapril effects on resistance artery structure and function in hypertension.
    Naunyn Schmiedebergs Arch Pharmacol, 370(6): 444-51. [Abstract] [Full-text]
40. Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries.
    Am J Physiol Heart Circ Physiol, 288(1): H235-43. [Abstract] [Full-text]
41. Sex differences in renal injury and nitric oxide production in renal wrap hypertension.
    Am J Physiol Heart Circ Physiol, 288(1): H43-7. [Abstract] [Full-text]
42. Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system.
    Am J Physiol Heart Circ Physiol, 288(1): H111-5. [Abstract] [Full-text]
43. Mineral water intake reduces blood pressure among subjects with low urinary magnesium and calcium levels.
    BMC Public Health, 4(1): 56. [Abstract] [Full-text]
44. Hyponatremic-hypertensive syndrome with extensive and reversible renal defects.
    Pediatr Nephrol, 20(1): 102-4. [Abstract] [Full-text]
45. The "weight" of fetal growth restriction in 437 hypertensive pregnancies.
    Arch Gynecol Obstet, 270(4): 214-6. [Abstract] [Full-text]
46. Pharmacologically distinct cardiovascular effects of box jellyfish (Chironex fleckeri) venom and a tentacle-only extract in rats.
    Toxicol Lett, 155(2): 219-26. [Abstract] [Full-text]
47. Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension.
    Obes Surg, 14(10): 1335-42. [Abstract] [Full-text]
48. Echocardiographic changes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension Register.
    J Hum Hypertens, 19(1): 69-75. [Abstract] [Full-text]
49. Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age.
    J Hum Hypertens, 19(1): 21-31. [Abstract] [Full-text]
50. The financial cost of optimising blood pressure control.
    J Hum Hypertens, 19(1): 83-4. [Abstract] [Full-text]
51. Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II.
    J Hum Hypertens, 19(1): 33-45. [Abstract] [Full-text]
52. Genetic variations related to hypertension: a review.
    J Hum Hypertens, 19(1): 7-19. [Abstract] [Full-text]
53. Comparing office-based and ambulatory blood pressure monitoring in clinical trials.
    J Hum Hypertens, 19(1): 77-82. [Abstract] [Full-text]
54. Blood pressure and atherosclerotic plaques in carotid, aortic and femoral arteries in elderly Finns with diabetes mellitus or impaired glucose tolerance.
    J Hum Hypertens, 19(1): 85-91. [Abstract] [Full-text]
55. Associations of short-term weight changes and weight cycling with incidence of essential hypertension in the EPIC-Potsdam Study.
    J Hum Hypertens, 19(1): 61-7. [Abstract] [Full-text]
56. Is hypertension an inflammatory disease?
    Med Hypotheses, 64(2): 236-40. [Abstract] [Full-text]
57. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy.
    J Am Coll Cardiol, 44(12): 2349-54. [Abstract] [Full-text]
58. Gender difference in functional properties of Na,K-ATPase in the heart of spontaneously hypertensive rats.
    Life Sci, 76(9): 971-82. [Abstract] [Full-text]
59. Age-related increase of pulse pressure and plasminogen activator inhibitor-1 I/D gene polymorphism in essential hypertension.
    J Intern Med, 257(1): 93-9. [Abstract] [Full-text]
60. Chronic disease risk in central New York dairy farmers: results from a large health survey 1989-1999.
    Am J Ind Med, 47(1): 20-6. [Abstract] [Full-text]
61. Pattern of drug utilization among hypertensives in a Nigerian teaching hospital.
    Pharmacoepidemiol Drug Saf, 14(1): 69-74. [Abstract] [Full-text]
62. Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.
    J Gen Intern Med, 19(12): 1181-91. [Abstract] [Full-text]
63. Optimizing microarray in experimental hypertension.
    Kidney Int, 67(1): 364-70. [Abstract] [Full-text]
64. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.
    Kidney Int, 67(1): 237-47. [Abstract] [Full-text]
65. Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean).
    Kidney Int, 67(1): 61-9. [Abstract] [Full-text]
66. Hypertension and survival in chronic hemodialysis patients--past lessons and future opportunities.
    Kidney Int, 67(1): 1-13. [Abstract] [Full-text]
67. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography.
    Circulation, 110(25): 3808-14. [Abstract] [Full-text]
68. Effect of diabetes and hypertension on obesity-related mortality.
    Surgery, 137(1): 16-25. [Abstract] [Full-text]
69. Hypertensive stress increases dispersion of repolarization.
    Pacing Clin Electrophysiol, 27(12): 1603-9. [Abstract] [Full-text]
70. Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria.
    Kidney Int Suppl. [Abstract] [Full-text]
71. Microalbuminuria in hypertensive patients: evaluation of one-year treatment with irbesartan.
    Kidney Int Suppl. [Abstract] [Full-text]
72. Efficacy of moxonidine in the treatment of hypertension in obese, noncontrolled hypertensive patients.
    Kidney Int Suppl. [Abstract] [Full-text]
73. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study.
    Int J Epidemiol, 33(6): 1345-52. [Abstract] [Full-text]
74. Serum cystatin C for assessment of glomerular filtration rate in hypertensive disorders of pregnancy.
    Hypertens Pregnancy, 23(3): 309-17. [Abstract] [Full-text]
75. Pregnancy and severe chronic hypertension: maternal outcome.
    Hypertens Pregnancy, 23(3): 285-93. [Abstract] [Full-text]
76. Maternal deaths associated with hypertensive disorders of pregnancy: a population-based study.
    Hypertens Pregnancy, 23(3): 247-56. [Abstract] [Full-text]
77. Impaired functional recovery after stroke in the stroke-prone spontaneously hypertensive rat.
    Stroke, 36(1): 135-41. [Abstract] [Full-text]
78. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy).
    Am J Cardiol, 95(1): 132-6. [Abstract] [Full-text]
79. Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension.
    Am J Cardiol, 95(1): 129-31. [Abstract] [Full-text]
80. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes.
    Am J Cardiol, 95(1): 29-35. [Abstract] [Full-text]
81. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period.
    Transplant Proc, 36(9): 2675-8. [Abstract] [Full-text]
82. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.
    Hypertension, 45(1): 142-61. [Abstract] [Full-text]
83. Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage.
    Hypertension, 45(1): 109-14. [Abstract] [Full-text]
84. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
    Hypertension, 45(1): 46-52. [Abstract] [Full-text]
85. Obesity-associated hypertension: new insights into mechanisms.
    Hypertension, 45(1): 9-14. [Abstract] [Full-text]
86. Birth weight and blood pressure in childhood: results from the Health Survey for England.
    Hypertension, 45(1): 75-9. [Abstract] [Full-text]
87. Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats.
    Hypertension, 45(1): 103-8. [Abstract] [Full-text]
88. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study.
    Hypertension, 45(1): 34-8. [Abstract] [Full-text]
89. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.
    Hypertension, 45(1): 28-33. [Abstract] [Full-text]
90. Plasma sodium: ignored and underestimated.
    Hypertension, 45(1): 98-102. [Abstract] [Full-text]
91. Novel approach to examining first cardiovascular events after hypertension onset.
    Hypertension, 45(1): 39-45. [Abstract] [Full-text]
92. Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?
    Hypertension, 45(1): 92-7. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.